rct
2022
High Quality
Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial
Unknown authors
Published in Journal of the European Academy of Dermatology and Venereology
Key Findings
Topical finasteride significantly improved target-area hair count versus placebo with an effect similar to oral finasteride and less systemic DHT suppression.
Conclusions
Localized DHT reduction can achieve scalp benefit while limiting systemic androgen suppression.
Outcomes Measured
Topical finasteride significantly improves hair count compared to placebo and is well tolerated. Its effect is similar to that of oral finasteride.
Study Details
Year:2022
Quality Score:8/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.